FreshLeaf Analytics

Analyzing the Australian Cannabis Industry With Rhys Cohen

We sat down with FreshLeaf Analytics' Principal Consultant, Rhys Cohen, about his thoughts on Australia's cannabis industry and the future of cannabis. Australia's medical cannabis...

May Sees Record High SAS-B Approvals For Cannabis Medicines

Medicinal cannabis approvals in Australia via the Special Access Scheme Category B route saw 4,133 approvals for the month of May 2020. For the month of May, the number of Australi...

FreshLeaf Analytics Publishes "Most Comprehensive" Study of Australian Cannabis Market

FreshLeaf Analytics has released an in-depth analysis of the patients, products and pricing of the Australian cannabis industry. The Southern Cannabis Holding Company's global res...

Australian Cannabis Industry off to a slow start in 2020

3,151 SAS-B approvals were issued in January 2020, down from 3,679 in December. A single month of negative growth is not a trend, and January and December are both short months wi...

Australia's Most Comprehensive Medicinal Cannabis Report Published for Q1 2020

FreshLeaf Analytics has released an in-depth analysis of the patients, products and pricing of the Australian cannabis industry for Q1 2020.The Southern Cannabis Holding Company's ...

Australian Medical Marijuana Prescriptions Steady Amid COVID-19

Medicinal cannabis approvals in Australia via the Special Access Scheme Category B route saw 3,378 prescriptions for the month of April 2020. The COVID-19 crisis has brought the Au...

Medical cannabis approvals in 2019 power through the 25,000 mark

The final data set for 2019 Special Access Scheme Category B approvals for medical cannabis has been released with 3,682 approvals issued in December. That brings the total for the...

Australian Patient Access Skyrockets 23% in October

Another record month for medicinal cannabis approvals in Australia via the Special Access Scheme Category B route! 3,594 approvals were issued in October 2019. Exclusive data colla...